We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $160M
1-Year Est. Return 8.57%
This Fund
S&P 500
This Quarter Est. Return
+15.98%
1 Year Est. Return
+8.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
+$15.4M
Cap. Flow
+$1.25M
Cap. Flow %
0.88%
Top 10 Hldgs %
49.55%
Holding
52
New
6
Increased
14
Reduced
22
Closed
7

Top Buys

Rank Stock Value
1
SLDB icon
Solid Biosciences
SLDB
+$3.84M
2
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$2.35M
3
ATNX
Athenex, Inc. Common Stock
ATNX
+$2.3M
4
ARGX icon
argenx
ARGX
+$2.21M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$2.19M

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.33M
2
XLRN
Acceleron Pharma
XLRN
+$1.98M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$1.84M
4
IMMU
Immunomedics Inc
IMMU
+$1.76M
5
AWI icon
Armstrong World Industries
AWI
+$1.66M

Sector Composition

Rank Sector Weight
1 Healthcare 52.79%
2 Financials 31.36%
3 Consumer Discretionary 8.42%
4 Industrials 2.47%
5 Technology 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMMU
51
DELISTED
Immunomedics Inc
IMMU
– –
-123,101
Closed -$1.76M
LJPC
52
DELISTED
La Jolla Pharmaceutical Company
LJPC
– –
-149,013
Closed -$1.41M
1 2
3

Similar funds

SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
LCA
Legend Capital Advisors New York $160M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return
BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM

Emory University's Q1 2019 Portfolio in Review

As of Q1 2019, Emory University held 52 positions worth $142M, up 12% from $127M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Emory University's Q1 2019 filing shows 6 new, 14 increased, 22 reduced and 7 closed positions. Its largest new stake was Orchard Therapeutics plc American Depositary Shares: 15,640 shares worth $2.8M. The largest sale was Alnylam Pharmaceuticals, an estimated $2.33M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 48% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Emory University's largest Q1 2019 buy was Orchard Therapeutics plc American Depositary Shares: 15,640 shares worth $2.8M.
  • Emory University added most to Solid Biosciences in Q1 2019, an estimated $3.84M increase.
  • Emory University's biggest Q1 2019 reduction was Global Blood Therapeutics, Inc., cutting an estimated $829K.
  • Emory University fully exited Alnylam Pharmaceuticals in Q1 2019, selling an estimated $2.33M.
  • Emory University's ten largest holdings make up 50% of its $142M portfolio in Q1 2019.
  • Emory University opened 6 new positions and closed 7 in Q1 2019.
  • Emory University's portfolio value rose 12% quarter-over-quarter to $142M.

Based on Emory University's 13F filing for Q1 2019, filed 9 May 2019.